US EditionImpact of MASLD on the Risk of Hepatocellular Carcinoma Following Viral Cure in Hepatitis C
Summary by Medical Xpress
2 Articles
2 Articles
All
Left
1
Center
1
Right
Impact of MASLD on the risk of hepatocellular carcinoma following viral cure in hepatitis C
Hepatitis C virus (HCV) infection is highly associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD), with a diagnosis requiring the presence of steatotic liver disease (SLD) along with at least one of five cardiometabolic risk factors (CMRFs), including obesity, arterial hypertension (HTN), type 2 diabetes (T2D)/prediabetes, and dyslipidemia.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
